Latest Breaking News On - Cervical node - Page 1 : comparemela.com

BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors

/PRNewswire/ BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced results from.

United statesUnited kingdomMoran meirJohn laceyPhilip serlinPrnewswire biolinerx ltdLifesci advisorsExchange commission onBiolinerx ltdAgalimmune ltdStudy met primary endpointSeek publicationComplete data analysisChief executive officerTumor cancer typeSquamous cell

BioLineRx (BLRX) Report Results from Phase 1/2a Study of AGI-134

BioLineRx (BLRX) Report Results from Phase 1/2a Study of AGI-134
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomPhilip serlinBiolinerx ltdChief executive officerTumor cancer typeSquamous cellCervical node